NRN, Neurosurgical Research Network
496 subscribers
1 photo
9 links
NRN is a new USERN interest group for students interested in the field of neurosurgery to have the opportunity to do high quality research, learn, and make new connections.

Website: www.usern.tums.ac.ir/Group/Info/NRN
Email: [email protected]
Download Telegram
Channel name was changed to «NRN, Neurosurgical Research Network»
Neurosurgical Research Network (NRN) is recruiting members.
NRN is a new USERN interest group for individuals interested in the field of neurosurgery to have the opportunity to do high-quality research, learn and make new connections. We are going to recruit members within the next month for our first research program. Any neurosurgery resident or medical student interested in neurosurgery can join NRN if he/she shows consistency and motivation.

Please fill out the below form by May 15th, you will receive an email with information regarding the introduction session which will be held in person. Although no prerequisite is required, we encourage applicants to get familiar with basic research skills (Scientific writing and advanced searching) prior to the in-person session.

https://docs.google.com/forms/d/e/1FAIpQLSfpydHKnCWAA1-IFshLgYcTicpm7j3fn9FUp4PPIhW28XYFVg/viewform?usp=sf_link

@NRN_IG
@USERN_NET
Our group recruitment is over. Thanks to everyone who filled out the form. You will be notified of your application result via email within the next two weeks after reviewing your answers.
Dear all

We are glad for your enthusiasm to join NRN. More than 150 medical students and residents applied to join NRN during our first recruitment session. We have decided to not exclude anyone based on their motivation letter as many junior students have not been previously introduced to writing a motivation letter.

We have divided applicants into three groups based on their previous experiences. Emails have been sent out to the first two groups of applicants (with more research experiences). We will contact the rest to attend the virtual session held in Zoom this Friday for further instructions.

Please check your emails during these few days.


NRN Team
Please only communicate with our team through this email address:

[email protected]
📃Sample outline:

Topic: Enteroviral Infections in XLA

Introduction:

-Background: Explanation about enteroviral infections, X-Linked Agammaglobulinemia (XLA) and a brief history on research investigating viral infection co-morbidities in XLA.

-Objectives: a review of recent researches about development and treatment of this kind of infections.

Review:

-Enteroviruses: explanation about enteroviruses, their types and types of infections they can cause.

-Immunodeficiency: clarifying immunodeficiency. Explaining XLA and its causes, symptoms, epidemiology.

-Enteroviral infections co-morbidity in XLA: explaining relation between these kind of infections and XLA using case studies from former studies. Discussing treatment for these conditions and their results.
Our team is launching two new systematic review projects in the fields of pediatric neurosurgery and spine.
We are looking for eager students who have previous experience and familiarity with systematic review to be our collaborators. Due to our limited timeline, projects need to be finished within 3 weeks.
Please send two of your systematic reviews along with a description of your role in the project to this email:

[email protected]
Our last round of recruitment resulted in 9 papers:
2 World Neurosurgery
3 JNS Focus
1 Neurosurgery
2 JNS
1 Neurosurgical Review

We are recruiting new members.
Please email us if you are interested in neurosurgery
(Radiosurgery, Neuro-Oncology, Cerebrovascular projects).

Projects are systematic reviews.

[email protected]
The Neurosurgical Research Network is a distinguished research association dedicated to advancing the field of neurosurgery 🧠🔬
Our scope encompasses critical areas such as cerebrovascular disorders, radiosurgery, neuro-oncology, and related disciplines. Committed to excellence, we strive to drive innovation and contribute to transformative advancements in neurosurgical care and research.

Our network has a robust history of impactful peer-reviewed publications and has fostered collaborations with esteemed professors and researchers from leading institutions, including Johns Hopkins University, University of Virginia, University of Chicago, Mayo Clinic, and other globally recognized academic centers. These partnerships underscore our commitment to rigorous, high-quality research that shapes the future of neurosurgery.

⭐️We are currently engaged in several cutting-edge projects, including original research studies and systematic reviews, aimed at addressing pressing challenges in the field. We invite researchers, clinicians, and academics who share our passion for neurosurgery to join us in these endeavors⭐️

📝For those interested in contributing to our mission or collaborating on our ongoing projects, please contact us at [email protected] Together, we can advance the frontiers of neurosurgical science.

@NRN_IG
NRN, Neurosurgical Research Network pinned «The Neurosurgical Research Network is a distinguished research association dedicated to advancing the field of neurosurgery 🧠🔬 Our scope encompasses critical areas such as cerebrovascular disorders, radiosurgery, neuro-oncology, and related disciplines. Committed…»
Prophylactic Cranial Irradiation for Small Cell Lung Cancer

A meta-analysis of 74 studies, spanning 1983 to 2022 and including 31,551 small cell lung cancer (SCLC) patients, has shed light on the effectiveness of prophylactic cranial irradiation (PCI):
1. Limited-Stage SCLC: Patients receiving PCI experienced significantly better overall survival (OS), progression-free survival (PFS), and brain metastasis–free survival (BMFS) compared to those who did not receive PCI.

2. Delayed Brain Metastases: PCI was associated with a significant delay in the development of brain metastases and a reduced incidence of brain metastases in limited-stage SCLC patients.

3. Extensive-Stage SCLC: The benefits of PCI were less clear for patients with extensive-stage SCLC, particularly when combined with adequate MRI surveillance, suggesting limited efficacy in this group.

Link to the paper

@NRN_IG
2
Is more always better in treating dural AVFs?

A study by NRN published in Neurosurgical Focus compared a single treatment (SRS radiation) vs. a combo treatment (SRS + embolization).

🔬 Finding 1: Efficacy is IDENTICAL!
The study found no significant difference in success rates. Both approaches closed off the problematic blood vessels at a rate of ~65%. Symptom improvement was also the same.

🔬 Finding 2: Simpler may be SAFER.
Adverse events were rare overall, but the data showed they were more commonly linked to the group that received the extra embolization procedure.

The Takeaway: For many patients, the less invasive approach of SRS alone is just as effective as the combination therapy. This research suggests reserving the combo treatment for more complex cases, saving patients added risk and burden.

@NRN_IG
🚀 Research Projects Starting Soon!

We are preparing to launch several projects very soon, and we’re looking for motivated individuals to join the team.

To ensure we can start right away, we kindly ask that anyone interested in participating send their CV to the following email address as soon as possible.
[email protected]

DEADLINE: September 25th
@NRN_IG
NRN, Neurosurgical Research Network pinned «🚀 Research Projects Starting Soon! We are preparing to launch several projects very soon, and we’re looking for motivated individuals to join the team. To ensure we can start right away, we kindly ask that anyone interested in participating send their CV…»
Less than 12 hours left!
Applications for our research projects are closing soon.
If you’re interested but haven’t sent your CV yet, email it now before the deadline passes! 🚀
NRN, Neurosurgical Research Network pinned « Less than 12 hours left! Applications for our research projects are closing soon. If you’re interested but haven’t sent your CV yet, email it now before the deadline passes! 🚀»